Discounted Cash Flow Calculation for OTCPK:MYDP using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for
is arrived at by discounting future cash flows to their present value using the 2 stage method.
We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
OTCPK:MYDP DCF 1st Stage: Next 10 year cash flow forecast
The current share price of
is above its future cash flow value.
Often investors are willing to pay a
for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Dougherty's Pharmacy's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dougherty's Pharmacy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Consumer Retailing industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Dougherty's Pharmacy's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Dougherty's Pharmacy's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare Dougherty's Pharmacy's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if Dougherty's Pharmacy is high growth as no earnings estimate data is available.
Unable to determine if Dougherty's Pharmacy is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Dougherty's Pharmacy's filings and announcements here.
Dougherty's Pharmacy's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Dougherty's Pharmacy's finances.
The net worth of a company is the difference between its assets and liabilities.
Dougherty's Pharmacy's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Dougherty's Pharmacy's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Dougherty's Pharmacy's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Dougherty's Pharmacy has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Stewart I. Edington serves as President, Chief Executive Officer and Interim Chief Financial Officer at Dougherty's Pharmacy, Inc. since February 07, 2019 and its Director since March 2019. He joins Dougherty’s from Gelson’s Pharmacy, where he served as Director of Operations from 2016 to 2017. Previously, he was Vice President of Pharmacy Operations at Haggen Food & Pharmacy from 2015 to 2016. He served in various roles at Albertsons, including Divisional Pharmacy Manager from 2003 to 2011. He served as Vice President of Pharmacy Operations at Albertsons, LLC from August 19, 2011 to December 2013. Mr. Edington has been with Albertsons since 2003, when he served as a Pharmacy Manager in the Phoenix, Ariz., area. Since 2006, he served as Pharmacy Manager for Albertsons' Florida division. He was also an integral part of the turnaround team during his tenure at Albertsons, working closely with Cerberus Capital Management, L.P., a private equity firm that owns and operates Albertsons.
Insufficient data for Stewart to compare compensation growth.
Insufficient data for Stewart to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the
management team in years:
The average tenure for the Dougherty's Pharmacy management team is less than 2 years, this suggests a new team.
Chairman of the Board & Secretary
Managing Director of Business Development
Consultant & Advisor
Executive Vice President of Sales and Marketing
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the Dougherty's Pharmacy board of directors is less than 3 years, this suggests a new board.
Board of Directors
Chairman of the Board & Secretary
Who owns this company?
Recent Insider Trading
More shares have been bought than sold by Dougherty's Pharmacy insiders in the past 3 months, but not in substantial volumes.
Dougherty’s Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty’s Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty’s Pharmacy, Inc. in May 2017. Dougherty’s Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.